ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EVA KOJNOK

Internal Medicine

5,198

$277K

286
252 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $56

CHRISTOPHER CLARK DO

Internal Medicine

5,121

$270K

253
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $56

KIN LUI M.D.

Internal Medicine

6,420

$275K

360
285 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

MARTI LIDDELL M.D.

Internal Medicine

2,243

$108K

252
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

RUSSELL HAVLICEK MD

Internal Medicine

10,319

$552K

557
479 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

JAMES MARTIN MD

Internal Medicine

1,807

$98.7K

181
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

ROBERT ORY MD

Internal Medicine

9,163

$518K

535
452 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

JAMES CAMPBELL M.D.

Internal Medicine

8,153

$451K

355
324 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

CARYN JACKSON MD

Internal Medicine

3,976

$203K

222
120 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

I JEN CHEN MD

Internal Medicine

11,281

$535K

374
365 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

TOBY LONG M.D.

Internal Medicine

7,162

$337K

419
352 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

ROBERT DAVIS MD

Internal Medicine

7,174

$297K

477
419 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $56

SANDRA DIANGI MD

Internal Medicine

7,301

$497K

481
426 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $56

JOHANNA WANG MD

Internal Medicine

8,938

$449K

586
466 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

GARY GRETCH MD

Internal Medicine

6,991

$429K

376
334 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

GERALD CRAIGG M.D.

Internal Medicine

5,137

$315K

174
115 are 65+

26%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

YUN SUHR MD

Internal Medicine

6,397

$293K

390
350 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

JOHN FLOYD MD

Internal Medicine

10,963

$588K

506
466 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

RITA SNOW MD

Internal Medicine

7,070

$326K

311
278 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

ANDREW PERRY MD

Internal Medicine

4,778

$265K

184
66 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

PATRICK LYNCH MD

Internal Medicine

11,903

$470K

605
507 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $56

MEGAN SPOHR MD

Internal Medicine

5,380

$232K

259
219 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

SHELLY FINN

Internal Medicine

5,444

$292K

517
440 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

EILEEN BAILEY MD

Internal Medicine

3,768

$214K

212
180 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

MYTHILI RAMACHANDRAN M.D.

Internal Medicine

9,940

$491K

338
265 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank